{"entity":{"id":"roberto-de-almeida-gil","kind":"person","name":"Roberto de Almeida Gil","aka":[],"tldr":"Director-General of Brazil's Instituto Nacional de Câncer (INCA), the Ministry of Health body that coordinates national cancer control.","summary":"Roberto de Almeida Gil is Director-General (Diretor-geral) of the Instituto Nacional de Câncer (INCA) in Rio de Janeiro, the Brazilian Ministry of Health institute responsible for national cancer prevention, surveillance, care, teaching and research. A medical oncologist by background, he leads INCA's hospital units and its national cancer control programmes.","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://www.gov.br/inca/pt-br/acesso-a-informacao/institucional/quem-e-quem"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Gil+RA%5BAuthor%5D+INCA"}],"tags":["leadership","cancer control","public health"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["inca-brazil"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Director-General","institutionId":"inca-brazil","specialisms":["Medical oncology","Cancer control policy","Public health"],"profiles":[{"label":"Institution profile","url":"https://www.gov.br/inca/pt-br/acesso-a-informacao/institucional/quem-e-quem"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Gil+RA%5BAuthor%5D+INCA"}],"papers":[{"title":"A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix.","journal":"Journal of Clinical Oncology","year":1991,"url":"https://doi.org/10.1200/jco.1991.9.6.970","doi":"10.1200/jco.1991.9.6.970","note":"OpenAlex author record matched by institution"},{"title":"A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus","journal":"Cancer","year":1991,"url":"https://doi.org/10.1002/1097-0142(19910501)67:9<2258::aid-cncr2820670908>3.0.co;2-g","doi":"10.1002/1097-0142(19910501)67:9<2258::aid-cncr2820670908>3.0.co;2-g","note":"OpenAlex author record matched by institution"},{"title":"Efficacy and Safety Associated With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma","journal":"JAMA Network Open","year":2021,"url":"https://doi.org/10.1001/jamanetworkopen.2021.36128","doi":"10.1001/jamanetworkopen.2021.36128","note":"OpenAlex author record matched by institution"}],"orcid":"0000-0001-9684-415X"},"route":"/people/roberto-de-almeida-gil/","neighbours":{"institution":[{"id":"inca-brazil","kind":"institution","name":"Instituto Nacional de Câncer (INCA)","route":"/institutions/inca-brazil/"}]}}